ANI Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	285.59	144.86	221.12	48.23	100.3
Short-Term Investments	9.13	6.31	-	-	-
Cash & Short-Term Investments	294.72	151.17	221.12	48.23	100.3
Cash Growth	94.96%	-31.64%	358.49%	-51.92%	1175.43%
Accounts Receivable	281.08	221.73	162.08	165.44	128.53
Inventory	143.07	136.78	111.2	105.36	81.69
Other Current Assets	34.25	18.01	25.42	25.24	11.26
Total Current Assets	753.12	527.68	519.82	344.26	321.78
Net Property, Plant & Equipment	62.48	56.86	44.59	43.25	52.67
Other Intangible Assets	479.53	541.83	209.01	251.64	294.12
Goodwill	62.48	59.99	28.22	28.22	27.89
Other Long-Term Assets	82.78	97.33	102.78	92.72	75.14
Total Assets	1,440	1,284	904.42	760.09	771.6
Accounts Payable	62.58	45.66	36.68	29.31	22.97
Accrued Expenses	147.3	92.8	57.84	35.89	27.89
Short-Term Debt	17.27	9.17	0.85	0.85	0.83
Other Current Liabilities	50.96	46.05	50.11	33.4	35.83
Total Current Liabilities	278.11	193.68	145.48	99.44	87.54
Long-Term Debt	599.77	614.92	284.82	285.67	286.52
Other Long-Term Liabilities	21.77	46.57	16.53	36.44	38.8
Total Long-Term Liabilities	621.54	661.49	301.35	322.11	325.32
Total Liabilities	899.65	855.17	446.82	421.55	412.86
Common Stock	0	0	0	0	0
Treasury Stock	-33.25	-21.04	-10.08	-5.09	-3.14
Additional Paid-in Capital	596.04	519.65	514.1	403.9	387.84
Accumulated Other Comprehensive Income	1.03	5.34	8.86	12.17	-3.06
Retained Earnings	-23.1	-100.28	-80.13	-97.29	-47.77
Total Common Shareholders' Equity	540.72	403.68	432.75	313.69	333.89
Minority Interest	-	24.85	24.85	24.85	24.85
Shareholders' Equity	540.72	428.53	457.6	338.54	358.74
Total Liabilities & Equity	1,440	1,284	904.42	760.09	771.6
Total Debt	617.04	624.09	285.67	286.52	287.35
Net Cash (Debt)	-322.32	-472.92	-64.55	-238.29	-187.05
Net Cash Per Share	-15.18	-24.48	-3.55	-14.65	-
Book Value	540.72	403.68	432.75	313.69	333.89
Book Value Per Share	25.47	20.90	23.79	19.29	-
Tangible Book Value	-1.28	-198.14	195.52	33.83	11.88
Tangible Book Value Per Share	-0.06	-10.26	10.75	2.08	-

Updated Feb 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q